Abstract
During a pharmacy and therapeutics committee meeting, discussion about new, high-cost hepatitis C treatments prompted me to consider the role of specialty pharmacy (SP) within the industry as a whole. A colleague found issue with limiting patients to an SP, arguing that face-to-face communications are most effective and that patients should be able to choose where SPECIALTY PHARMACY SECTION they receive their specialty pharmaceuticals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
